Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

09. Décembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2920


	Articles 1 - 20 / 58387

	Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study. Pancreas Zou S, Wen C, Li F, Jiang L, Tian Q, Chen H, Deng X, Peng C, Shen B, Zhan Q. PMID: 41359420 [PubMed - as supplied by publisher]
	Spleen Preservation in Solid Pseudopapillary Neoplasms: Evidence, Rationale, and Practical Considerations. Am Surg Lenzi MC, Carvalho MCAP, Rocha GFS, Juca RH, De Oliveira Filho M, Souza DLS, Fernandes MM, Santana AUL, Camarotti TAF, Portugal MM, De Mello EB. PMID: 41359292 [PubMed - as supplied by publisher]
	Palliative care in pancreatic cancer: effects on symptom burden, survival, and place of death. Support Care Cancer Allende-Pérez S, Melchor-Ruan J, Cruz-Sánchez JJ, Martínez-Barrios I, Peña-Nieves A, Herrera-Guerrero MI, Ruiz-Garcia E, Cabrera-Galeana PA. PMID: 41359199 [PubMed - indexed for MEDLINE]
	Unusual complications following endoscopic ultrasound-guided hepaticogastrostomy: A call for refined techniques and dedicated devices. World J Gastroenterol Choi JH, Paik WH. PMID: 41358179 [PubMed - indexed for MEDLINE]
	Cystic tumors of the pancreas: Current perspectives on diagnosis and management. World J Gastroenterol Shumka N, Karagyozov PI. PMID: 41358177 [PubMed - indexed for MEDLINE]
	Pancreatic cancer in 2025: Have we found a solution? World J Gastroenterol Tonini V, Zanni M. PMID: 41358172 [PubMed - indexed for MEDLINE]
	Preoperative malignancy risk assessment in pancreatic cystic neoplasms using clinical and laboratory parameters. World J Gastrointest Surg Martli HF, Acehan F, , , Sürel AA, Er S, Tez M. PMID: 41357639 [PubMed]
	Clinicopathological features of patients undergoing surgery for pancreatic cancer with very early postoperative recurrence. World J Gastrointest Surg Martl, , Alta, Eri, Çayhan V, Ersoy O, Ke, Tez M. PMID: 41357630 [PubMed]
	Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis. EClinicalMedicine Sheikh M, Domingues A, Alcala K, Langdon R, Mariosa D, Feng X, Sarich P, Weber MF, Viallon V, Fournier A, Kamangar F, Malekzadeh R, Gillette C, Vitolins MZ, Adams MCB, Virani S, Ebrahimi E, Dudding T, Galesloot TE, Kiemeney LA, Rothman N, Koutros S, Zhou J, Pearson SA, Parat MO, Brennan P, Johansson M, Davey Smith G, Robbins HA. PMID: 41357337 [PubMed]
	Can Symptom Clusters Predict Stage, Resectability, and Survival in Pancreatic Cancer? Cancer Manag Res Demir MS, A. PMID: 41356429 [PubMed]
	KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target. Cancer Manag Res Hou W. PMID: 41356425 [PubMed]
	The Burden of Pancreatic Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction up to 2036: A Systemic Analysis of the Global Burden of Diseases Study 2021. Cancer Med Guo T, Zhu W, Hui Y, Wang Y, Zhou T, Shen W, Li L, Yang Y, Cheng H. PMID: 41355376 [PubMed - indexed for MEDLINE]
	Integrated ultrasound radiomics and clinical data to predict PD-1 blockade efficacy in unresectable hepatocellular carcinoma. BMC Gastroenterol Jiang D, Liu Z, Wang K, Qian Y, Feng J, Gong L, Ren J, Xiang Y, Zhang F, Liu L, Zhou H, Liang C, Wei W, Zang B, Kong C, Li Y, Cheng S. PMID: 41354910 [PubMed - as supplied by publisher]
	Adaptive Drug Resistance Mechanisms Driven by Non-coding RNA-Protein Interaction Networks in Hepatocellular Carcinoma. Crit Rev Oncol Hematol Tian Y, Ouyang K, Wu H, Liao H, He L, Luo T, Ma K, Mao X, Wang F, Xiong H. PMID: 41354412 [PubMed - as supplied by publisher]
	Does Adjuvant Therapy in Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas Improve Survival? A Systematic Review and Meta-Analysis Using Trial Sequential Analysis. World J Surg Ingaldi C, D'Ambra V, Ricci C, Alberici L, Migliori M, Di Marco M, Palloni A, Mosconi C, Serra C, Casadei R. PMID: 41353715 [PubMed - as supplied by publisher]
	An ultrasensitive miRNA-25 aptasensor based on Co@CNTs nanoaggregates for early detection of pancreatic cancer. Biosens Bioelectron Han Y, Zhou M, Zhu M, Zhang W, Liu Y, Liu T, Chu Z, Jin W. PMID: 41352058 [PubMed - as supplied by publisher]
	Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan. Fam Cancer Arif S, Muhammad N, Naeemi H, Rashid MU. PMID: 41351753 [PubMed - indexed for MEDLINE]
	Development of a nomogram for predicting microvascular invasion in patients with hepatocellular carcinoma. BMC Cancer Li J, Huo S, Ma J, Ren L, Liu L, Lu Y, Tang S, Chen D, Jin L, Liao W. PMID: 41350826 [PubMed - indexed for MEDLINE]
	Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and prognostication of pancreatic cancer. NPJ Precis Oncol Shishido SN, Suresh D, Mason J, Liu Q, Park K, Watson R, Nissen N, Gaddam S, Lo SK, Pandol S, Kuhn P. PMID: 41350390 [PubMed - as supplied by publisher]
	Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer. Pharmacol Res Roskoski R Jr. PMID: 41349848 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58387

Page 1 de 2920



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité